Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Venditti

Showing results (141-150 of 230) with videos related to

Pageof 23
Sort By:
Journal of Hepatology|March 26, 2013
Increased risk of cognitive impairment in cirrhotic patients with bacterial infectionsManuela Merli, Cristina Lucidi, Ilaria Pentassuglio, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing <i>K. pneumoniae</i> Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the BedsideAlessandra Oliva, Ambrogio Curtolo, Lorenzo Volpicelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired PneumoniaFrancesco Violi, Roberto Cangemi, Marco Falcone, et al.
International Journal of Antimicrobial Agents|November 4, 2011
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapyMarco Falcone, Alessandro Russo, Maria Elena Pompeo, et al.
Hepatology (Baltimore, Md.)|November 4, 2015
An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trialManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
International Journal of Antimicrobial Agents|January 21, 2015
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in ItalyAlessandro Russo, Floriana Campanile, Marco Falcone, et al.
Open Forum Infectious Diseases|July 21, 2023
Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i> Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Infections: A Retrospective, Observational, 2-Center Clinical StudyAlessandra Oliva, Laura Campogiani, Giulia Savelloni, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical IsolatesAlessandra Carattoli, Gabriele Arcari, Giulia Bibbolino, et al.
Expert Review of Anti-Infective Therapy|September 15, 2017
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of EndocarditisSimone Giuliano, Maurizio Guastalegname, Alessandro Russo, et al.
International Journal of Antimicrobial Agents|June 12, 2022
An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and bla<sub>NDM</sub>: evaluation of the global dissemination of these resistance determinantsFederica Sacco, Giammarco Raponi, Alessandra Oliva, et al.
Pageof 23

Showing results (141-150 of 230) with videos related to

Sort By:
Pageof 23
Journal of Hepatology|March 26, 2013
Increased risk of cognitive impairment in cirrhotic patients with bacterial infectionsManuela Merli, Cristina Lucidi, Ilaria Pentassuglio, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing <i>K. pneumoniae</i> Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the BedsideAlessandra Oliva, Ambrogio Curtolo, Lorenzo Volpicelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired PneumoniaFrancesco Violi, Roberto Cangemi, Marco Falcone, et al.
International Journal of Antimicrobial Agents|November 4, 2011
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapyMarco Falcone, Alessandro Russo, Maria Elena Pompeo, et al.
Hepatology (Baltimore, Md.)|November 4, 2015
An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trialManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
International Journal of Antimicrobial Agents|January 21, 2015
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in ItalyAlessandro Russo, Floriana Campanile, Marco Falcone, et al.
Open Forum Infectious Diseases|July 21, 2023
Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i> Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Infections: A Retrospective, Observational, 2-Center Clinical StudyAlessandra Oliva, Laura Campogiani, Giulia Savelloni, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical IsolatesAlessandra Carattoli, Gabriele Arcari, Giulia Bibbolino, et al.
Expert Review of Anti-Infective Therapy|September 15, 2017
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of EndocarditisSimone Giuliano, Maurizio Guastalegname, Alessandro Russo, et al.
International Journal of Antimicrobial Agents|June 12, 2022
An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and bla<sub>NDM</sub>: evaluation of the global dissemination of these resistance determinantsFederica Sacco, Giammarco Raponi, Alessandra Oliva, et al.
Pageof 23